carvedilol has been researched along with oxidopamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Huang, Y; Jin, M; Liu, A; Pi, R; Qin, J; Shen, W; Wang, L; Wang, R; Wen, S | 1 |
1 other study(ies) available for carvedilol and oxidopamine
| Article | Year |
|---|---|
Carvedilol attenuates 6-hydroxydopamine-induced cell death in PC12 cells: involvement of Akt and Nrf2/ARE pathways.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Cell Death; NF-E2-Related Factor 2; Oxidopamine; PC12 Cells; Propanolamines; Proto-Oncogene Proteins c-akt; Rats | 2014 |